Alpine Woods Capital Investors LLC acquired a new stake in Medtronic PLC (NYSE: MDT) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 68,491 shares of the medical technology company's stock, valued at approximately $5,358,000. Medtronic comprises about 1.2% of Alpine Woods Capital

Medtronic is rated a 'Buy,' favored for its attractive valuation and potential upside from its CAS segment despite recent underperformance. CAS, now 5-6% of revenue, is annualizing above $2B and could reach $3B in a few years if execution remains strong. Guidance targets 6.75%-7.25% organic growth and $5.90-$6.00 EPS, but calendar effects and MiniMed separation timing are key variables.

BlackRock Inc. lifted its position in shares of Medtronic PLC (NYSE: MDT) by 0.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 114,020,787 shares of the medical technology company's stock after buying an additional 838,220 shares during the period.

GALWAY, Ireland, Aug. 20, 2026 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 20, 2026, approved the company's cash dividend for the second quarter of fiscal year 2027 of $0.72 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in June 2026.

Medtronic is reiterated as a "Buy," with shares offering over 10% fundamental upside and attractive valuation metrics. Q4 delivered 6.6% organic revenue growth—best in a decade—driven by double-digit gains in the Cardiovascular and Diabetes segments. FY 2027 guidance targets 6.75%-7.25% organic revenue growth and $5.90-$6.00 non-GAAP EPS, despite tariff and competitive headwinds.

Capital Analysts LLC boosted its stake in Medtronic PLC (NYSE: MDT) by 5.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 168,785 shares of the medical technology company's stock after buying an additional 9,294 shares during the quarter. Capital Analysts LLC's holdings

Fox Run Management L.L.C. lifted its stake in Medtronic PLC (NYSE: MDT) by 364.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,397 shares of the medical technology company's stock after acquiring an additional 18,364 shares during the

In the most recent trading session, Medtronic (MDT) closed at $92.09, indicating a +1.64% shift from the previous trading day.

SpaceX seems promising, but the stock looks too expensive at current levels. Intuitive Surgical has lagged broader equities this year, but it's a great buy on the dip.

Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or Agilent Technologies (A). But which of these two stocks presents investors with the better value opportunity right now?